MapLight Therapeutics clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   ML-007C-MA · Schizophrenia

   Trial sites expanded: 42 → 45 locations

   MapLight Therapeutics·Phase 2· NCT07459647· Registry history of NCT07459647 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

2. Minor

   ML-007C-MA · Alzheimer's Disease Psychosis

   Trial sites expanded: 55 → 62 locations

   MapLight Therapeutics·Phase 2· NCT06887192· Registry history of NCT06887192 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.